Translating Science into Survival: Report on the Inaugural International Cancer Immunotherapy Conference

Cancer Immunol Res. 2016 Jan;4(1):3-11. doi: 10.1158/2326-6066.cir-15-0279.

Abstract

The inaugural International Cancer Immunotherapy Conference, cohosted by the Cancer Research Institute (CRI), the American Association for Cancer Research (AACR), the Association for Cancer Immunotherapy (CIMT), and the European Academy of Tumor Immunology (EATI), was held in New York City on September 16–19, 2015. The conference brought together nearly 1,400 scientists, clinicians, regulators, patient advocates, and other stakeholders to discuss the latest scientific developments in cancer immunology and immunotherapy, as well as the regulatory hurdles facing new drug development. This conference report summarizes the main themes that emerged during the 4-day meeting.

Publication types

  • Congress

MeSH terms

  • Animals
  • Cancer Vaccines / administration & dosage
  • Clinical Trials as Topic
  • Humans
  • Immunotherapy*
  • Neoplasms / immunology
  • Neoplasms / mortality
  • Neoplasms / therapy*
  • Treatment Outcome

Substances

  • Cancer Vaccines